Während viele eine Zinssenkung im September erwarten, sagte ein Ökonom, dass Bitcoin erst dann alle positiven Effekte einpreist, wenn der US-Präsident den Nachfolger von Fed-Chef Jerome Powell bekannt gibt.
Is BNB heading to a new ATH as market recovery begins? Check forecast
Key takeaways
- Binance’s BNB is trading at $845 after adding 1.5% to its value.
- The coin could surge to a new all-time high as the broader crypto market shows signs of a recovery.
BNB tops $845
The cryptocurrency market has had a bearish start to the week, with Bitcoin hitting the $115k level while Ether dropped below $8,200. However, the market is showing signs of recovery, and most altcoins are now in the green.
One of the strongest coins in recent weeks is BNB, Binance’s native coin. BNB hit a new all-time high of $868 five days ago and has generally been bullish since the start of the year. The recent surge saw its all-time high cross the $120 billion mark for the first time in its history.
After dropping to a low of $818 earlier on Monday, BNB has now bounced back above $840 and could rally to a new all-time high in the coming hours or days. BNB’s rally showcases Binance’s status as the largest cryptocurrency in the world in terms of daily trading volume.
BNB targets $900 amid bullish resurgence
The BNB/USD 4-hour chart remains bullish and efficient despite the market’s recent correction. The technical indicators remain bullish, unlike those of other leading cryptocurrencies like BTC and XRP.
The RSI of 54 shows that BNB hasn’t entered into the bearish territory, and the bulls could easily regain control of the market. The MACD lines are also within the bullish zone, suggesting that buyers are currently in control.
If the market recovery continues, BNB could surpass its all-time high price of $868 over the next few hours. An extended rally would allow BNB to touch the $900 mark for the first time in its history. BNB’s medium-term target remains $1,000 as analysts remain extremely bullish on the coin.
However, if the bulls fail to take control, BNB could retest Monday’s low of $818 and drop lower to the TLQ at $793.
The post Is BNB heading to a new ATH as market recovery begins? Check forecast appeared first on CoinJournal.
Chainlink price forecast as key metrics point to increased onchain activity
- Chainlink price broke to highs $26 before correcting slightly.
- LINK is surging amid a spike in onchain activity.
- Partnerships and adoption trends remain bullish for Chainlink.
Chainlink (LINK) broke above $26 for the first time in months on Monday, surging amid a notable spike in onchain activity.
As LINK pares gains amid broader profit taking, analysts are saying the recent explosion of key network metrics could allow bulls to breach the supply wall at $30 as they target the all-time high of $52 seen over four years ago.
Chainlink sees significant surge in onchain activity
According to Santiment, Chainlink’s onchain activity has witnessed a significant spike in the past week.
For instance, on Sunday, August 17, a total of 9,813 unique LINK addresses executed at least one transaction, while the next day saw more than 9,625 new LINK wallets.
Per the onchain analytics provider, both metrics represent the blockchain network’s highest levels for the year.
“Onchain activity has been even more impressive than the price,” Santiment analysts noted.
Partnerships and LINK reserve
Recently, Visa’s head of crypto, Cuy Sheffield, explained via Visa’s Tokenized podcast, that Chainlink is a major pull for institutional entry into crypto.
Apart from Visa, Chainlink has partnered with ANZ, China AMC, and Fidelity International to bring cross-chain, cross-border settlements to tokenized assets across Australia and Hong Kong.
A Mastercard partnership is also huge for LINK.
Chainlink Data Streams is another solution seeing huge integration. Data Streams are now live for U.S. equities and exchange-traded funds such as AAPL, NVDA and CRCL.
Chainlink also recently partnered with Intercontinental Exchange, the parent company of the New York Stock Exchange.
“Using ICE’s Consolidated Feed data as an input into Chainlink’s derived FX and precious metals rates onchain via Chainlink’s institutional-grade infrastructure is a watershed moment in the evolution of global markets,” said Fernando Vazquez, president of capital markets at Chainlink Labs. “This collaboration signals a pivotal shift towards a unified, globally accessible onchain financial system, with hundreds of trillions in assets on a clear path to tokenization.”
Chainlink Reserve, an effort launched to support Chainlink’s traction in the DeFi and TradFi ecosystems, is also a major boost.
As well as being geared towards establishing Chainlink as a standard solution for global crypto adoption, the program bolsters its tokenized assets growth.
What’s next for LINK price?
Chainlink’s price action amid the surge in network activity suggests bulls are confident in LINK.
Having broken above $20 and strengthened to $26, Chainlink is showing resilience. While bears have a say on immediate LINK price action, analysts say the altcoin could be on the cusp of a significant breakout.
While the key metrics indicate that Chainlink’s network growth is outpacing price gains, there are more bulls who are upbeat about.
A confluence of catalysts such as network integration across decentralized and traditional finance, whale accumulation and macro conditions, is what could propel LINK toward its ATH and into price discovery mode.
LINK traded at the all-time high above $52 in May 2021, a level bulls may target if market conditions align. Currently, the altcoin is on an uptrend since hitting lows of $16 on Aug. 6.
The post Chainlink price forecast as key metrics point to increased onchain activity appeared first on CoinJournal.
XRP climbs above $3 after ETF delay; Check forecast
Key takeaways
- XRP is up nearly 2% in the last 24 hours and has climbed above $3.
- The positive performance comes despite the SEC’s ETF delay.
SEC delays spot XRP ETF applications
XRP, the native coin of the Ripple network, is up nearly 2% in the last 24 hours as it bounces back from its recent low. The positive performance comes despite the United States Securities and Exchange Commission (SEC) delaying its decision on Canary Capital, CoinShares, Bitwise, Grayscale, and 21Shares’ spot XRP ETF applications.
The regulatory agency stated that it had extended its decision on the 21Shares Core XRP Trust from the set deadline of August 20, adding 60 days, setting the new deadline for October 19.
The SEC also delayed decisions on the 21Shares Trust, Grayscale, CoinShares, and Bitwise XRP ETF filings. The delay will provide the SEC enough time to seek public opinion on the proposal and assess any regulatory concerns associated with the Exchange Act.
Analysts expect the SEC to issue final decisions on all eight pending spot ETF applications, including Franklin Templeton, REX-Osprey, WisdomTree, and five others, by October 18.
XRP aims for $3.3 as the market slowly recovers
The XRP/USD 4-hour chart remains bullish and efficient despite XRP’s recent poor performance. The long-term trend remains bullish as XRP looks to set a new all-time high in the near to medium term.
After holding around the $2.9 support, XRP could rally higher in the short term. The technical indicators are still bearish but point to signs of growing momentum. The MACD lines are within the bearish region, but could soon crossover into the positive zone. The RSI of 43 shows that XRP is not in the oversold region, and bulls could regain control with ease.
If the recovery improves, XRP could surge past the first major resistance level at $3.39 in the next few hours or days. Support from the broader market would allow it to surpass its recent high of $3.66.
However, if the bearish trend grows stronger, XRP could retest the $2.72 support level over the next few days. The low of $2.08 created last month remains strong and could stand in the short to medium term.
The post XRP climbs above $3 after ETF delay; Check forecast appeared first on CoinJournal.
Bio Protocol hits 6-month high as harmonic pattern signals further upside
- Bio Protocol funds $80K brain health trial, earning CLAW royalty tokens.
- Staked BIO tokens rise to 125M, tightening supply and boosting demand.
- Harmonic chart pattern signals a possible BIO price rally toward $0.1787.
The Bio Protocol (BIO) token has regained strong momentum after a sharp pullback earlier this month, climbing to a six-month high of $0.1514 before settling near $0.138.
The recovery follows a string of bullish catalysts, ranging from real-world biotech partnerships to a surge in staking activity, while traders are now watching technical signals that hint at further upside.
BIO price recovery sparks fresh momentum
After dropping to $0.0962 during the recent correction, BIO has staged an impressive rebound of more than 50% in a matter of days.
The strong recovery comes at a time when the broader crypto market has been under selling pressure, yet Bio Protocol has managed to move against the trend.
At press time, the token was trading nearly 100% higher on the month, underscoring its growing resilience.
Trading activity has also intensified. Daily volumes have spiked by more than 700% last week, crossing $440 million as new investors piled in.
This sharp increase in liquidity has strengthened confidence that BIO’s market depth is improving, making it more attractive for both retail and institutional traders.
Clinical trial funding lifts sentiment
One of the strongest drivers of BIO’s price rally has been the announcement of its first major biotech initiative.
Through its partner Cerebrum DAO, the Bio Protocol community approved $80,000 in funding for a Phase 2 human clinical trial of Percepta, a supplement targeting memory loss and neurodegeneration.
Big week in the Biosphere 🧪
• Launched Bio Markets w/ real-time DeSci analytics & BioAgent trading coming
• 125M+ $BIO staked + 1M BioXP Boost
• Funding human trial for Percepta $CLAW
• Molecule V2 DeSci equity
• $BeeARD psilocybin derivativeRead the full weekly update: https://t.co/l5lH2Utcjo
— Bio Protocol (@BioProtocol) August 17, 2025
The deal not only gives Bio Protocol direct exposure to real-world biotech outcomes but also provides it with CLAW tokens.
These tokens are tied to royalties from Percepta sales, creating a potential revenue-sharing model that sets BIO apart from other speculative altcoins.
Investors see this as a sign that the project is delivering on its promise to link decentralised finance with biotech innovation.
BIO token staking reduces supply pressure
Another factor supporting BIO’s price is the steady growth in token staking.
The amount of staked BIO tokens has climbed to 125 million, representing about 3.5% of the circulating supply.
This is a significant jump from 25 million staked tokens earlier in August.
By staking, holders earn BioXP, which provides access to new ecosystem assets such as CLAW. More importantly, staking reduces the liquid supply on exchanges.
As a result, when demand rises, the price impact is magnified. Traders are already drawing comparisons to earlier DeFi tokens where similar dynamics sparked explosive rallies.
Technical setup points to higher targets
From a technical perspective, BIO has cleared several key resistance levels. It moved above the 7-day simple moving average at $0.116 and broke through the 23.6% Fibonacci retracement at $0.128.
The next resistance sits near $0.145, with momentum indicators suggesting strong buying pressure despite a relative strength index that hovers near overbought territory.
Adding to this outlook, analysts have identified a harmonic ABCD pattern unfolding on the 4-hour chart.
The harmonic ABCD pattern began with a rally from $0.0559 to $0.0956 before retracing and launching into a bullish CD-leg.
The extension of this structure projects an upside target near $0.1800, which traders are closely monitoring as the next profit-taking zone.
Bio Protocol price outlook remains cautiously bullish
While the harmonic setup points to further upside, traders remain alert to the possibility of consolidation.
A failure to hold above the 50-period moving average, currently near $0.1159, could open the door to short-term corrections.
Still, the combination of real-world utility, staking-driven scarcity, and a favourable technical structure has left sentiment firmly bullish.
Bio Protocol’s six-month high marks an important milestone for a token launched less than a year ago.
But whether it can sustain this rally will depend on both the outcome of the Percepta trial and the broader adoption of decentralised science models.
The post Bio Protocol hits 6-month high as harmonic pattern signals further upside appeared first on CoinJournal.